Clinical Trials Browser

Phase 1/2 × Withdrawn × tremelimumab × Clear all

NCT06608940 2026-02-19

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

Phase 1/2 Withdrawn

Gastrointestinal

Liver Neoplasms

NCT05120622 2023-10-31

Rideau

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms